Aria F. Olumi, MD, Named Chief of Urology at Beth Israel Deaconess Medical Center
Chloe Meck (BIDMC Communications) firstname.lastname@example.org
MAY 10, 2018
BOSTON – Aria F. Olumi, MD, an accomplished clinician, educator and investigator, has been named Chief of Urology in the Department of Surgery at Beth Israel Deaconess Medical Center. Olumi is internationally recognized for his multifaceted work in the field of urology and directs a laboratory funded by the National Institute of Health that is focused on examining the different growth patterns of the prostate gland in healthy men.
“We welcome Dr. Olumi and are confident his compassionate care for patients and families, his devotion to his trainees and colleagues, and his thoughtful and respectful leadership will further enhance the division’s commitment to excellence in patient care and research,” said Elliot Chaikof, MD, PhD, Chair of the Department of Surgery.
Olumi, also a Professor of Surgery at Harvard Medical School, formerly served as Co-Director of Urologic Oncology and Program Director of the Residency in Urology at Massachusetts General Hospital. His clinical practice is focused on caring for patients with urologic tumors through open and minimally invasive, robotic, laparoscopic, and endoscopic approaches.
“I am honored to have been selected to succeed my mentor, Dr. William DeWolf, who has been instrumental in my career as a surgeon-scientist and clinician,” said Olumi. “I am excited about returning to BIDMC, where I launched my academic career, and look forward to the opportunities in advancing the mission and goals of the institution.”
In addition to his clinical practice, Olumi serves as Chair of the Research Council for the American Urological Association, the largest international urologic society with a membership of over 22,000. In this role, Olumi has been responsible for oversight of multiple committees that develop plans for public research advocacy at the national level with the NIH and the Department of Defense, national conference planning, and enhancing research and educational opportunities for the urologic community. He also has been an associate editor of the Journal of Urology.
Olumi earned his medical degree from the University of Southern California School of Medicine, and was a molecular medicine fellow at the University of California, San Francisco School of Medicine, where he participated in a research fellowship under Thea Tlsty, PhD, Director of the Center for Translational Research in the Molecular Genetics of Cancer. He completed the Harvard Longwood Residency Program in Urology and is board certified in urology.
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding.
BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Rehabilitation Center and is a research partner of Dana-Farber/Harvard Cancer Center and the Jackson Laboratory. BIDMC is the official hospital of the Boston Red Sox. For more information, visit www.bidmc.org.
BIDMC is part of Beth Israel Lahey Health, a new health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,000 physicians and 35,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.